アリスエ ノブコ
Arisue Nobuko
有末 伸子 所属 医学部 医学科 職種 助教 |
|
論文種別 | 総説 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism. |
掲載誌名 | 正式名:Parasitology international 略 称:Parasitol Int ISSNコード:18730329/13835769 |
掲載区分 | 国外 |
巻・号・頁 | 99,pp.102845 |
著者・共著者 | Palacpac Nirianne Marie Q, Ishii Ken J, Arisue Nobuko, Tougan Takahiro, Horii Toshihiro |
発行年月 | 2024/04 |
概要 | The call for second generation malaria vaccines needs not only the identification of novel candidate antigens or adjuvants but also a better understanding of immune responses and the underlying protective processes. Plasmodium parasites have evolved a range of strategies to manipulate the host immune system to guarantee survival and establish parasitism. These immune evasion strategies hamper efforts to develop effective malaria vaccines. In the case of a malaria vaccine targeting the N-terminal domain of P. falciparum serine repeat antigen 5 (SE36), now in clinical trials, we observed reduced responsiveness (lowered immunogenicity) which may be attributed to immune tolerance/immune suppression. Here, immunogenicity data and insights into the immune responses to SE36 antigen from epidemiological studies and clinical trials are summarized. Documenting these observations is important to help identify gaps for SE36 continued development and engender hope that highly effective blood-stage/multi-stage vaccines can be achieved. |
DOI | 10.1016/j.parint.2023.102845 |
PMID | 38101534 |